Critics and some medical observers have expressed caution regarding the broad definition of cardiovascular-kidney-metabolic (CKM) syndrome, warning that it risks labeling a vast majority of the population as 'diseased.' With nearly 90 percent of adults falling into the category of having at least one risk factor, there is concern that the medical community may be over-medicalizing common conditions associated with aging or modern lifestyle habits. Skeptics argue that such a wide net could lead to unnecessary anxiety among the public and place an undue burden on primary care resources.
There is also the concern that the focus on a new syndrome might distract from the practical challenges of addressing the root causes of these health issues. Critics point out that factors like unhealthy diets, physical inactivity, and environmental stressors are often driven by socioeconomic conditions that a new medical label cannot solve. Simply categorizing these issues under a new name does not necessarily provide patients with the resources, time, or affordable access to healthy food and safe exercise spaces needed to make meaningful changes.
Furthermore, some experts worry that the emphasis on a 'syndrome' could lead to an over-reliance on pharmaceutical interventions for individuals who might otherwise be managed through lifestyle changes alone. There is a risk that the medicalization of these risk factors could lead to a 'treatment-first' mentality, where the focus shifts toward managing numbers on a chart rather than addressing the holistic well-being of the patient. Accountability-focused observers stress that public health efforts should remain centered on accessible, sustainable lifestyle support rather than creating complex diagnostic categories that may confuse patients more than they help.